Ginkgo Bioworks Holdings Inc

NYSE:DNAHealthcareCBOEFTSE:MRUTrussell2000

——At close · Market cap — · Next earnings Thu 5 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	79.6%	58.7%	57.3%	78.5%	83.0%	81.5%	—	—
Operating margin	−178.8%	−582.6%	−462.4%	−343.8%	−246.5%	−185.3%	−185.3%	+0.0 pts
Net margin	−165.2%	−583.1%	−440.6%	−355.1%	−240.9%	−183.8%	−183.8%	+0.0 pts
EBITDA margin	−141.7%	−575.7%	−431.2%	−326.6%	−213.3%	−149.6%	—	—
Return on equity	−27.4%	−121.6%	−121.2%	−81.4%	−76.4%	−61.5%	−61.5%	+0.0 pts
Return on assets	−18.8%	−88.4%	−82.9%	−53.6%	−39.7%	−27.9%	−27.9%	+0.0 pts
Return on capital employed	−22.8%	−94.4%	−93.3%	−57.6%	−44.1%	−30.8%	—	—
Debt / equity	0.0×	0.0×	0.3×	0.2×	0.7×	0.9×	0.9×	+0.0%
Debt / assets	2.5%	1.1%	17.4%	14.4%	34.0%	39.3%	—	—
Interest coverage	−57.5×	−770.5×	−20,839.2×	−9,294.7×	−5,954.9×	0.0×	—	—
Current ratio	5.8×	12.8×	8.4×	6.1×	5.6×	4.9×	4.9×	+0.0%
Quick ratio	5.7×	12.8×	8.4×	6.1×	5.6×	4.9×	—	—
Cash ratio	5.2×	11.5×	7.6×	5.8×	5.2×	1.7×	1.7×	+0.0%
Asset turnover	0.1×	0.2×	0.2×	0.2×	0.2×	0.2×	—	—
Inventory turnover	1.7×	38.6×	46.8×	1,174.0×	—	—	—	—
Receivables turnover	3.5×	2.1×	5.7×	14.0×	10.1×	7.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.